MODERN TREATMENT METHODS OF HEART FAILURE
Ключевые слова:
Heart failure, cardiovascular disease, pharmacological therapy, cardiac resynchronization therapy, implantable cardioverter-defibrillatorАннотация
Heart failure is one of the leading causes of morbidity and mortality worldwide and remains a major challenge for modern healthcare systems. The increasing prevalence of cardiovascular diseases, population aging, hypertension, diabetes mellitus, and obesity has contributed to the growing burden of heart failure. Recent advances in cardiovascular medicine have led to the development of innovative treatment strategies that significantly improve patient outcomes. This article examines contemporary approaches to heart failure management, including pharmacological therapy, device-based interventions, and advanced treatment options for severe cases. Particular attention is given to angiotensin receptor-neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, sodium-glucose cotransporter-2 inhibitors, implantable cardiac devices, mechanical circulatory support systems, and heart transplantation. The article also discusses future perspectives in heart failure treatment, including personalized medicine, artificial intelligence, gene therapy, and regenerative medicine. The findings indicate that modern multidisciplinary approaches contribute to improved survival, reduced hospitalization rates, and enhanced quality of life among patients with heart failure.
##plugins.themes.default.displayStats.downloads##
Библиографические ссылки
1. Heidenreich P.A., Bozkurt B., Aguilar D. et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure // Circulation. – 2022. – Vol. 145, No. 18. – P. e895–e1032.
2. Anker S.D., Butler J., Filippatos G. et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction // New England Journal of Medicine. – 2021. – Vol. 385, No. 16. – P. 1451–1461
3. Packer M., Anker S.D., Butler J. et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure // New England Journal of Medicine. – 2020. – Vol. 383, No. 15. – P. 1413–1424.
4. Yancy C.W., Januzzi J.L., Allen L.A. et al. 2021 ACC Expert Consensus Decision Pathway on Heart Failure Treatment Optimization // Journal of the American College of Cardiology. – 2021. – Vol. 79, No. 17. – P. 1757–1780.
5. Beghini A., Rosano G.M.C., Metra M. 2024 Update in Heart Failure // European Journal of Heart Failure. – 2024. – Vol. 26, No. 1. – P. 8–25.
6. Hoevelmann J., Bauersachs J., Anker S.D. Update on Clinical Heart Failure Trials // Clinical Research in Cardiology. – 2025. – Vol. 114. – P. 1–15.
7. Kosiborod M.N., Butler J., et al. Semaglutide in Patients with Obesity-Related Heart Failure with Preserved Ejection Fraction // The Lancet. – 2024.
8. Ismoilova Y.A., Agababyan I.R., Akhatova V.P. Organization of Specialized Medical Care for Patients with Chronic Heart Failure // Journal of Biomedicine and Practice. – 2022. – No. 5. – P. 97–103.
9. Kityan S.A. Prevalence of Chronic Heart Failure in Andijan of the Republic of Uzbekistan // World of Science. – 2022. – Vol. 3, No. 11. – P. 1–6.
10. Abdullaev T.A., Tsoi I.A., Khudoyberganov O.K., Gulamov H.A. Innovative Approaches to Remote Monitoring in the Management of Chronic Heart Failure // Cardiology of Uzbekistan. – 2024. – Vol. 1, No. 3.
